Vetter is Expanding its Facilities and Investing in the Future
16 November 2007
Vetter Pharma Fertigung of Ravensburg, Germany, has started the construction of a new facility for visual inspection and secondary packaging. Vetter, the leading manufacturer of aseptic pre-filled application systems, will be adding the new building close to Ravensburg Vetter South (RVS), its existing state-of-the-art facility. The approximately 20-million-euro expansion will create more than 200 new jobs.
"This is an investment in the future, and with it we are laying the groundwork for Vetter's continuing success," said Thomas Otto, Managing Director of Vetter. "The new facility is being built due to customer demands in the growing market for homecare applications, including dual chamber syringes and cartridges for pen- and autoinjectors, and to meet new international requirements, such as the adoption of safety systems for anti-conterfeiting." The facility will be operating by the end of 2008.
In addition to its RVS location, the company has two other aseptic production facilities in the region. Vetter fills all common injection systems for international pharmaceutical and biotech companies. All of the company's facilities are autonomous and can be used for mutual back-up.
